Latest features in GaBI Journal, 2017, Issue 3

Author(s): Professor Philip D Walson, MD

It is clear that greater use of generics and biosimilars could greatly decrease healthcare costs and thereby increase availability of important medicines. It is equally clear that these potential savings are seldom achieved. The disconnect between what is possible and what is being achieved is related to a lack of trust on behalf of patients, […]

Read more →